The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Gold-Based Therapeutic Agents
Abstract
ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTGold-Based Therapeutic AgentsC. Frank ShawView Author Information The Department of Chemistry, Eastern Kentucky University, Richmond, Kentucky 40475-3124, and The Department of Chemistry, University of WisconsinMilwaukee, Milwaukee, Wisconsin 53201-0413 Cite this: Chem. Rev. 1999, 99, 9, 2589–2600Publication Date (Web):August 20, 1999Publication History Received11 May 1999Revised12 July 1999Published online20 August 1999Published inissue 8 September 1999https://pubs.acs.org/doi/10.1021/cr980431ohttps://doi.org/10.1021/cr980431oresearch-articleACS PublicationsCopyright © 1999 American Chemical SocietyRequest reuse permissionsArticle Views6574Altmetric-Citations848LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Biopolymers,Gold,Ligands,Metabolism,Peptides and proteins Get e-Alerts
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Relativistic effects in structural chemistry
Pyykko, P. (1988) · Chemical Reviews · doi:10.1021/cr00085a006 · Cited by 3,046
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-507_3 · Cited by 592
Inhibitory effects of a new oral gold compound on hela cells
Simon, T. M., Kunishima, D. H., Gj, V., & LORBER, A. (1979) · Cancer · Cited by 116
Schuhmann, D., Kubicka-Muranyi, M., Mirtcheva, J., Günther, J., Kind, P., & Gleichmann, E. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.7.2132 · Cited by 103
Cited by
The golden age: gold nanoparticles for biomedicine
Dreaden, E. C., Alkilany, A. M., Huang, X., Murphy, C. J., & El-Sayed, M. A. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15237h · Cited by 3,550
The gold–sulfur interface at the nanoscale
Häkkinen, H. (2012) · Nature Chemistry · doi:10.1038/nchem.1352 · Cited by 1,727
Luo, Z., Yuan, X., Yu, Y., Zhang, Q., Leong, D. T., Lee, J. Y., & Xie, J. (2012) · Journal of the American Chemical Society · doi:10.1021/ja306199p · Cited by 1,681
Negishi, Y., Nobusada, K., & Tsukuda, T. (2005) · Journal of the American Chemical Society · doi:10.1021/ja042218h · Cited by 1,646
Protein- and Peptide-Directed Syntheses of Inorganic Materials
Dickerson, M. B., Sandhage, K. H., & Naik, R. R. (2008) · Chemical Reviews · doi:10.1021/cr8002328 · Cited by 960
Biological properties of “naked” metal nanoparticles☆
BHATTACHARYA, R., & MUKHERJEE, P. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.013 · Cited by 917
Gold Nanoparticles for Photothermal Cancer Therapy
Vines, J. B., Yoon, J.-H., Ryu, N.-E., Lim, D.-J., & Park, H. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00167 · Cited by 906
Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future
Arvizo, R. R., Bhattacharyya, S., Kudgus, R. A., Giri, K., Bhattacharya, R., & Mukherjee, P. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15355f · Cited by 866
Chemical remodelling of cell surfaces in living animals
Prescher, J. A., Dube, D. H., & Bertozzi, C. R. (2004) · Nature · doi:10.1038/nature02791 · Cited by 842
On the medicinal chemistry of gold complexes as anticancer drugs
Ott, I. (2009) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2009.02.019 · Cited by 825
Copper Complexes as Anticancer Agents
Marzano, C., Pellei, M., Tisato, F., & Santini, C. (2009) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152009787313837 · Cited by 802
Copper in diseases and treatments, and copper‐based anticancer strategies
Tisato, F., Marzano, C., Porchia, M., Pellei, M., & Santini, C. (2010) · Medicinal Research Reviews · doi:10.1002/med.20174 · Cited by 797
The Medicinal Applications of Imidazolium Carbene−Metal Complexes
Hindi, K. M., Panzner, M. J., Tessier, C. A., Cannon, C. L., & Youngs, W. J. (2009) · Chemical Reviews · doi:10.1021/cr800500u · Cited by 776
Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs
Liu, W., & Gust, R. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35314h · Cited by 762
Nano-Gold Catalysis in Fine Chemical Synthesis
Zhang, Y., Cui, X., Shi, F., & Deng, Y. (2012) · Chemical Reviews · doi:10.1021/cr200260m · Cited by 670
Chemical biology of anticancer gold(iii) and gold(i) complexes
Zou, T., Lum, C. T., Lok, C.-N., Zhang, J.-J., & Che, C.-M. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00132c · Cited by 628
Therapeutic possibilities of plasmonically heated gold nanoparticles
Pissuwan, D., Valenzuela, S. M., & Cortie, M. B. (2006) · Trends in Biotechnology · doi:10.1016/j.tibtech.2005.12.004 · Cited by 620
van Rijt, S. H., & Sadler, P. J. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.09.003 · Cited by 592
Anticancer Activity of Metal Complexes: Involvement of Redox Processes
Jungwirth, U., Kowol, C. R., Keppler, B. K., Hartinger, C. G., Berger, W., & Heffeter, P. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3663 · Cited by 554
Recovery of precious metals through biosorption — A review
Das, N. (2010) · Hydrometallurgy · doi:10.1016/j.hydromet.2010.03.016 · Cited by 508
Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies
Nobili, S., Mini, E., Landini, I., Gabbiani, C., Casini, A., & Messori, L. (2010) · Medicinal Research Reviews · doi:10.1002/med.20168 · Cited by 503
Gold compounds as therapeutic agents for human diseases
Berners-Price, S. J., & Filipovska, A. (2011) · Metallomics · doi:10.1039/c1mt00062d · Cited by 495
Inorganic and metal nanoparticles and their antimicrobial activity in food packaging applications
Hoseinnejad, M., Jafari, S. M., & Katouzian, I. (2018) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2017.1332001 · Cited by 487
Targeting proteins with metal complexes
Meggers, E. (2009) · Chemical Communications · doi:10.1039/b813568a · Cited by 450
Rai, A., Prabhune, A., & Perry, C. C. (2010) · Journal of Materials Chemistry · doi:10.1039/c0jm00817f · Cited by 448
Metal based drugs: from serendipity to design
Fricker, S. P. (2007) · Dalton Transactions · doi:10.1039/b705551j · Cited by 414
Fernando, A., Weerawardene, K. L. D. M., Karimova, N. V., & Aikens, C. M. (2015) · Chemical Reviews · doi:10.1021/cr500506r · Cited by 403
Nune, S. K., Chanda, N., Shukla, R., Katti, K., Kulkarni, R. R., Thilakavathy, S., Mekapothula, S., Kannan, R., & Katti, K. V. (2009) · Journal of Materials Chemistry · doi:10.1039/b822015h · Cited by 397
Inorganic Nanoparticles in Cancer Therapy
Bhattacharyya, S., Kudgus, R. A., Bhattacharya, R., & Mukherjee, P. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0318-0 · Cited by 395
Metal Drugs and the Anticancer Immune Response
Englinger, B., Pirker, C., Heffeter, P., Terenzi, A., Kowol, C. R., Keppler, B. K., & Berger, W. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00396 · Cited by 355
Gold nanoparticles: From nanomedicine to nanosensing
Oyelere, A. (2008) · Nanotechnology, Science and Applications · doi:10.2147/nsa.s3707 · Cited by 350
Azcune, I., & Odriozola, I. (2016) · European Polymer Journal · doi:10.1016/j.eurpolymj.2016.09.023 · Cited by 339
Milacic, V., Chen, D., Ronconi, L., Landis-Piwowar, K. R., Fregona, D., & Dou, Q. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3017 · Cited by 317
The in vitro and in vivo toxicity of gold nanoparticles
Jia, Y.-P., Ma, B.-Y., Wei, X.-W., & Qian, Z.-Y. (2017) · Chinese Chemical Letters · doi:10.1016/j.cclet.2017.01.021 · Cited by 316
Ronconi, L., Marzano, C., Zanello, P., Corsini, M., Miolo, G., Maccà, C., Trevisan, A., & Fregona, D. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0509288 · Cited by 314
Barnard, P. J., Wedlock, L. E., Baker, M. V., Berners‐Price, S. J., Joyce, D. A., Skelton, B. W., & Steer, J. H. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200601526 · Cited by 260
Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase
Gandin, V., Fernandes, A. P., Rigobello, M. P., Dani, B., Sorrentino, F., Tisato, F., Björnstedt, M., Bindoli, A., Sturaro, A., Rella, R., et al. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.07.023 · Cited by 252
Thangamani, S., Maland, M., Mohammad, H., Pascuzzi, P. E., Avramova, L., Koehler, C. M., Hazbun, T. R., & Seleem, M. N. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00004 · Cited by 90
Sobhakumari, A., Love-Homan, L., Fletcher, E. V. M., Martin, S. M., Parsons, A. D., Spitz, D. R., Knudson, C. M., & Simons, A. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048175 · Cited by 80
Metadata
- Authors
- Shaw, C. F.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 1999-08-20
- Volume
- 99
- Issue
- 9
- Pages
- 2589-2600
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2047212216
- Cited by
- 990
- References
- 4
- FWCI
- 0.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.